Jiangsu Nhwa Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Jiangsu Nhwa Pharmaceutical has a total shareholder equity of CN¥7.1B and total debt of CN¥65.2M, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are CN¥8.1B and CN¥1.0B respectively. Jiangsu Nhwa Pharmaceutical's EBIT is CN¥1.2B making its interest coverage ratio -15.3. It has cash and short-term investments of CN¥3.8B.
Key information
0.9%
Debt to equity ratio
CN¥65.23m
Debt
| Interest coverage ratio | -15.3x |
| Cash | CN¥3.85b |
| Equity | CN¥7.10b |
| Total liabilities | CN¥1.02b |
| Total assets | CN¥8.13b |
Recent financial health updates
Jiangsu Nhwa Pharmaceutical (SZSE:002262) Has A Rock Solid Balance Sheet
Sep 20
Jiangsu Nhwa Pharmaceutical (SZSE:002262) Seems To Use Debt Rather Sparingly
Jun 16Recent updates
Jiangsu Nhwa Pharmaceutical Co., LTD (SZSE:002262) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Oct 28Is Now The Time To Put Jiangsu Nhwa Pharmaceutical (SZSE:002262) On Your Watchlist?
Oct 21Jiangsu Nhwa Pharmaceutical (SZSE:002262) Has A Rock Solid Balance Sheet
Sep 20The Market Doesn't Like What It Sees From Jiangsu Nhwa Pharmaceutical Co., LTD's (SZSE:002262) Earnings Yet
Sep 04Here's Why Jiangsu Nhwa Pharmaceutical (SZSE:002262) Has Caught The Eye Of Investors
Jul 22Jiangsu Nhwa Pharmaceutical (SZSE:002262) Seems To Use Debt Rather Sparingly
Jun 16Jiangsu Nhwa Pharmaceutical Co., LTD's (SZSE:002262) Share Price Is Matching Sentiment Around Its Earnings
May 09Jiangsu Nhwa Pharmaceutical (SZSE:002262) Ticks All The Boxes When It Comes To Earnings Growth
Apr 18Earnings Update: Jiangsu Nhwa Pharmaceutical Co., LTD (SZSE:002262) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Apr 02Financial Position Analysis
Short Term Liabilities: 002262's short term assets (CN¥5.9B) exceed its short term liabilities (CN¥929.3M).
Long Term Liabilities: 002262's short term assets (CN¥5.9B) exceed its long term liabilities (CN¥95.4M).
Debt to Equity History and Analysis
Debt Level: 002262 has more cash than its total debt.
Reducing Debt: 002262's debt to equity ratio has reduced from 10.6% to 0.9% over the past 5 years.
Debt Coverage: 002262's debt is well covered by operating cash flow (1687.6%).
Interest Coverage: 002262 earns more interest than it pays, so coverage of interest payments is not a concern.